A post-hoc analysis of the phase 3b JUMP trial found that ruxolitinib plus anemia supportive care maintained efficacy and reduced transfusion needs in patients with myelofibrosis.

Early detection of blood cancer can be life-saving. Here are five warning signs you must never overlook, according to an ...

Cellarity has dosed the first subject in a Phase I study of oral medication, CLY-124, to treat sickle cell disease (SCD).

A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according ...

Pune: Jyoti has seen her first-born go through regular blood transfusions due to her sickle cell and thalassaemia conditions. So she was fearful and h.

Clinical assessment of a subject with IDA may reveal manifestations of anaemia (eg, breathlessness, fatigue, heart failure) and on occasion more specifically of iron deficiency (such as angular ...

A new survey of 500 UK adults, conducted by LloydsPharmacy Online Doctor, found that only 25% of people would know the common ...

How new diagnostic pathways can support earlier diagnosis and appropriate management in patients with lower gastrointestinal ...

Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that the first subject has been dosed in a Phase 1 ...

Cohen, E. and Kubinak, N. (2025) A Rare Presentation of Cavernous Sinus Thrombosis in a Young Female. Surgical Science, 16, ...

In her presentation at AANP 2025, Dr Haylei Lorca includes case studies of 3 patients who present with atypical psychiatric symptoms.

USA: Researchers have found in a new study that even in the absence of anemia, iron deficiency (ID) during adolescence is ...